Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
Ind-Ra expects FY22 IPM to have witnessed 15% YoY sales growth, higher than the 8%-10% observed over the past five years, aided by the base effect
Essent continues to broaden its highly characterized, low passage primary cell catalog
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Subscribe To Our Newsletter & Stay Updated
